Eifert Sandra, Mair Helmut, Boulesteix Anne-Laure, Kilian Eckehard, Adamczak Martin, Reichart Bruno, Lamm Peter
Department of Cardiac Surgery, Ludwig Maximilians University, Munich, Germany. Sandra.Eifert@med. uni-muenchen.de
Vasc Health Risk Manag. 2010 Aug 9;6:495-501. doi: 10.2147/vhrm.s8560.
The number of percutaneous coronary interventions (PCI) prior to coronary artery bypass grafting (CABG) increased drastically during the last decade. Patients are referred for CABG with more severe coronary pathology, which may influence postoperative outcome. Outcomes of 200 CABG patients, collected consecutively in an observational study, were compared (mean follow-up: 5 years). Group A (n = 100, mean age 63 years, 20 women) had prior PCI before CABG, and group B (n = 100, mean age 66, 20 women) underwent primary CABG. In group A, the mean number of administered stents was 2. Statistically significant results were obtained for the following preoperative criteria: previous myocardial infarction: 54 vs 34 (P = 0.007), distribution of CAD (P < 0.0001), unstable angina: 27 vs 5 (P < 0.0001). For intraoperative data, the total number of established bypasses was 2.43 +/- 1.08 vs 2.08 +/- 1.08 (P = 0.017), with the number of arterial bypass grafts being: 1.26 +/- 0.82 vs 1.07 +/- 0.54 (P = 0.006). Regarding the postoperative course, significant results could be demonstrated for: adrenaline dosage (0.83 vs 0.41 mg/h; [p is not significant (ns)]) administered in 67 group A vs 47 group B patients (P = 0.006), and noradrenaline dosage (0.82 vs 0.87 mg/h; ns) administered in 46 group A vs 63 group B patients (P = 0.023), CK/troponine I (P = 0.002; P < 0.001), postoperative resuscitation (6 vs 0; P = 0.029), intra aortic balloon pump 12 vs 1 (P = 0.003), and 30-day mortality (9% in group A vs 1% in group B; P = 0.018). Clopidogrel was administered in 35% of patients with prior PCI and in 19% of patients without prior PCI (P = 0.016). Patients with prior PCI presented for CABG with more severe CAD. Morbidity, mortality and reoperation rate during mid term were significantly higher in patients with prior PCI.
在过去十年中,冠状动脉旁路移植术(CABG)前经皮冠状动脉介入治疗(PCI)的数量急剧增加。接受CABG治疗的患者冠状动脉病变更为严重,这可能会影响术后结果。在一项观察性研究中,连续收集了200例CABG患者的结果并进行比较(平均随访时间:5年)。A组(n = 100,平均年龄63岁,女性20例)在CABG前接受过PCI,B组(n = 100,平均年龄66岁,女性20例)接受初次CABG。在A组中,平均植入支架数量为2个。以下术前标准获得了具有统计学意义的结果:既往心肌梗死:54例对34例(P = 0.007),CAD分布(P < 0.0001),不稳定型心绞痛:27例对5例(P < 0.0001)。对于术中数据,建立旁路的总数为2.43±1.08对2.08±1.08(P = 0.017),动脉旁路移植的数量为:1.26±0.82对1.07±0.54(P = 0.006)。关于术后过程,以下方面可证明具有显著结果:67例A组患者与47例B组患者使用肾上腺素的剂量(0.83对0.41mg/h;[p无统计学意义(ns)])(P = 0.006),46例A组患者与63例B组患者使用去甲肾上腺素的剂量(0.82对0.87mg/h;ns)(P = 0.023),肌酸激酶/肌钙蛋白I(P = 0.002;P < 0.001),术后复苏(6例对0例;P = 0.029),主动脉内球囊反搏12例对1例(P = 0.003),以及30天死亡率(A组为9%对B组为1%;P = 0.018)。35%接受过PCI的患者和19%未接受过PCI的患者使用了氯吡格雷(P = 0.016)。接受过PCI的患者因CABG就诊时CAD更为严重。接受过PCI的患者中期的发病率、死亡率和再次手术率显著更高。